Total Payments
$11,489
2024 Payments
$45.82
Companies
10
Transactions
36
Medicare Patients
3,977
Medicare Billing
$446,908
Payment Breakdown by Category
Consulting$8,148 (70.9%)
Travel$2,363 (20.6%)
Food & Beverage$929.53 (8.1%)
Education$48.72 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,148 | 3 | 70.9% |
| Travel and Lodging | $2,363 | 11 | 20.6% |
| Food and Beverage | $929.53 | 19 | 8.1% |
| Education | $48.72 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $9,504 | 13 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $989.05 | 7 | $0 (2018) |
| Shionogi Inc | $814.28 | 7 | $0 (2020) |
| Insmed, Inc. | $48.72 | 3 | $0 (2022) |
| Inspire Medical Systems, Inc. | $45.82 | 1 | $0 (2024) |
| Philips Electronics North America Corporation | $25.68 | 1 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $18.56 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.13 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $13.54 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $13.10 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45.82 | 1 | Inspire Medical Systems, Inc. ($45.82) |
| 2023 | $9,534 | 15 | Regeneron Healthcare Solutions, Inc. ($9,504) |
| 2022 | $41.92 | 2 | Philips Electronics North America Corporation ($25.68) |
| 2021 | $34.80 | 2 | JAZZ PHARMACEUTICALS INC. ($18.56) |
| 2020 | $830.52 | 8 | Shionogi Inc ($814.28) |
| 2018 | $1,002 | 8 | Merck Sharp & Dohme Corporation ($989.05) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $45.82 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $4,753.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/08/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,716.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/08/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $679.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/08/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $51.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Respiratory | ||||||
| 09/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $288.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $142.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $119.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $76.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $170.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $385.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/20/2022 | Philips Electronics North America Corporation | (6571) Eagle Eye (Device) | Food and Beverage | Cash or cash equivalent | $25.68 | General |
| Category: Medical Device | ||||||
| 08/11/2022 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 11/17/2021 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug), XYWAV | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: NEUROLOGY | ||||||
| 06/24/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 12/08/2020 | Insmed, Inc. | — | Education | In-kind items and services | $16.24 | General |
| 02/06/2020 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $46.06 | General |
| 02/06/2020 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $19.74 | General |
| 02/06/2020 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $19.74 | General |
| 02/06/2020 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $17.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 736 | 887 | $369,872 | $91,810 |
| 2022 | 16 | 1,196 | 1,532 | $543,217 | $135,800 |
| 2021 | 16 | 1,012 | 1,289 | $419,537 | $112,564 |
| 2020 | 13 | 1,033 | 1,337 | $420,917 | $106,735 |
Total Patients
3,977
Total Services
5,045
Medicare Billing
$446,908
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 238 | 287 | $88,109 | $24,982 | 28.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 33 | 33 | $76,588 | $16,611 | 21.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 29 | 30 | $61,590 | $14,517 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $46,900 | $11,314 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 50 | $20,650 | $6,893 | 33.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 57 | $14,364 | $3,458 | 24.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 26 | $15,080 | $3,386 | 22.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 107 | 147 | $15,141 | $3,039 | 20.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 51 | 62 | $9,672 | $2,688 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,241 | $1,871 | 25.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 19 | $9,614 | $1,605 | 16.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 29 | 29 | $4,379 | $1,278 | 29.2% |
| 88738 | Hemoglobin measurement | Office | 2023 | 31 | 34 | $544.00 | $167.28 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 349 | 456 | $139,992 | $42,027 | 30.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 35 | 36 | $83,590 | $18,166 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 124 | 124 | $58,156 | $14,598 | 25.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 28 | 29 | $60,740 | $14,097 | 23.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 119 | $60,214 | $9,509 | 15.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 63 | $26,019 | $8,719 | 33.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 44 | $25,520 | $6,831 | 26.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 100 | 120 | $18,720 | $5,644 | 30.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 180 | 262 | $26,986 | $5,432 | 20.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 72 | $18,144 | $3,873 | 21.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 67 | 67 | $10,117 | $2,854 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $9,469 | $2,800 | 29.6% |
About Dr. Patrick Wright, M.D
Dr. Patrick Wright, M.D is a Pulmonary Disease healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811917164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Wright, M.D has received a total of $11,489 in payments from pharmaceutical and medical device companies, with $45.82 received in 2024. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($8,148).
As a Medicare-enrolled provider, Wright has provided services to 3,977 Medicare beneficiaries, totaling 5,045 services with total Medicare billing of $446,908. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Minneapolis, MN
- Active Since 07/20/2006
- Last Updated 09/03/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1811917164
Products in Payments
- DUPIXENT (Biological) $9,504
- MK-7264 (Drug) $989.05
- INSPIRE (Device) $45.82
- Arikayce (Drug) $32.48
- (6571) Eagle Eye (Device) $25.68
- XYREM (Drug) $18.56
- STIOLTO RESPIMAT (Drug) $16.13
- BREZTRI (Drug) $13.54
- Utibron (Drug) $13.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Minneapolis
Mitchell Kaye, M.d, M.D
Pulmonary Disease — Payments: $52,142
Pulmonary Disease $52,142
Dr. Ken Kunisaki, M.d, M.D
Pulmonary Disease — Payments: $9,515
Pulmonary Disease $9,515
Dr. Abdallah Abboud, M.d, M.D
Pulmonary Disease — Payments: $7,678
Pulmonary Disease $7,678
Abbie Begnaud, Md, MD
Pulmonary Disease — Payments: $5,506
Pulmonary Disease $5,506
Dr. Kevin Grullon, M.d, M.D
Pulmonary Disease — Payments: $3,020
Pulmonary Disease $3,020
Jagadish Patil, M.d, M.D
Pulmonary Disease — Payments: $1,242
Pulmonary Disease $1,242